Insider Sells 856 Shares of Beta Bionics Stock

Beta Bionics insider Mark Hopman reduces stake by 0.62%

Mar. 17, 2026 at 12:21am

Got story updates? Submit your updates here. ›

Beta Bionics, Inc. (NASDAQ:BBNX) insider Mark Hopman sold 856 shares of the company's stock on Tuesday, December 2nd. The shares were sold at an average price of $29.34, for a total value of $25,115.04. Following the sale, Hopman directly owned 138,277 shares in the company, valued at approximately $4,057,047.18. This transaction represents a 0.62% decrease in Hopman's ownership stake.

Why it matters

Insider transactions, such as stock sales, can provide insights into a company's performance and management's confidence in the business. Hopman's sale of a portion of his Beta Bionics holdings may signal a change in his outlook or the company's prospects.

The details

The sale was disclosed in a filing with the Securities & Exchange Commission. Hopman has made several other recent transactions, including selling 353 shares on March 4th and 834 shares on March 2nd.

  • The stock sale occurred on Tuesday, December 2nd.
  • Hopman also sold 353 shares on Wednesday, March 4th and 834 shares on Monday, March 2nd.

The players

Mark Hopman

An insider at Beta Bionics, Inc. (NASDAQ:BBNX).

Beta Bionics, Inc.

A clinical-stage medical device company focused on automated insulin delivery solutions for type 1 diabetes management.

Got photos? Submit your photos here. ›

The takeaway

This insider sale by Mark Hopman represents a small reduction in his ownership stake in Beta Bionics, potentially signaling a change in his outlook on the company's prospects. However, without further context or commentary from Hopman, it's difficult to draw definitive conclusions about the company's performance or future.